Live feed
Filing
SC 13G
SC 13G0000935836-20-000488·Keros Therapeutics, Inc.
Schedule 13G ownership disclosure
Keros Therapeutics Inc
Security class unavailable · CUSIP: 492327101
Event date: 2020-08-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,350,000
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-20-000488
- Form type
- SC 13G
- Filer
- Keros Therapeutics, Inc.
- CIK
- CIK 1664710
- Filed
- Aug 31, 2020
- Reporting period
- Aug 20, 2020
- Description
- Schedule 13G beneficial ownership